NDC 43826-044 - Guanfacine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43826-044
- Package NDCs from labels
- 43826-044-01
- Manufacturer
- Bora Pharmaceutical Laboratories Inc. | TWi Pharmaceuticals, Inc. Zhongli Plant
- Effective date
- 2024-01-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Guanfacine Tablets, USP | Bora Pharmaceutical Laboratories Inc. | TWi Pharmaceuticals, Inc. Zhongli Plant | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Guanfacine | GAUNFACINE | A2A Integrated Pharmaceuticals | 00c3b4d2-fc4d-4e68-9157-eb29d927deaf | 2025-02-28 | Adverse reactions | PML56A160O |
| Guanfacine | GUANFACINE | Bryant Ranch Prepack | 9d558d8e-8b55-41c6-8209-62b1f7bb0dd4 | 2025-02-04 | Warnings, Adverse reactions | PML56A160O |
| Guanfacine ER | GUANFACINE ER | Direct_Rx | fae2df3c-2298-a3e1-e053-6294a90aeac4 | 2025-01-22 | Warnings, Adverse reactions | PML56A160O |
| Guanfacine | GUANFACINE | NORTHSTAR RXLLC | 0b2afdab-8c92-463e-9734-f2c8b4200777 | 2024-12-27 | Warnings, Adverse reactions | PML56A160O |
| Guanfacine ER | GUANFACINE ER | Direct_rx | 286214e2-a65b-f43b-e063-6394a90a33be | 2024-12-03 | Warnings, Adverse reactions | PML56A160O |
| Guanfacine | GAUNFACINE | i3 Pharmaceuticals, LLC | 387b33dd-829d-4dab-afe4-078fd1559027 | 2024-11-05 | Adverse reactions | PML56A160O |
| Guanfacine | GUANFACINE | Fosun Pharma USA, Inc | 261c06ce-8708-d659-e063-6294a90ac381 | 2024-11-04 | Warnings, Adverse reactions | PML56A160O |
| Guanfacine Hydrochloride | GUANFACINE | Amneal Pharmaceuticals LLC | d9fdc4b4-5b00-46dd-8700-6e36ceaafb0e | 2024-10-25 | Adverse reactions | PML56A160O |
| Guanfacine Hydrochloride | GUANFACINE HYDROCHLORIDE | NORTHSTAR RX LLC | 83d0739b-46fd-6228-e85c-089611067a35 | 2024-07-15 | Adverse reactions | PML56A160O |
| Guanfacine | GUANFACINE | A-S Medication Solutions | 57b8ad03-a5d1-4218-8d3a-40b211da84e6 | 2024-04-15 | Warnings, Adverse reactions | PML56A160O |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| Guanfacine Hydrochloride | GUANFACINE HYDROCHLORIDE | XIROMED, LLC | 4f1e668a-37dd-44f4-ae99-3a1f6dba3eea | 2024-02-24 | Adverse reactions | PML56A160O |
| 0f833267-3175-c55d-e063-6394a90a5a31 | 0d018b4b-16bb-8ea3-e063-6294a90a18ba | 2024-01-22 | Adverse reactions | 0f833267-3175-c55d-e063-6394a90a5a31 0d018b4b-16bb-8ea3-e063-6294a90a18ba | ||
| Guanfacine | GUANFACINE | Epic Pharma, LLC | fac4a4c2-f5f0-46ef-b76b-315abe9136fa | 2023-11-08 | Adverse reactions | PML56A160O |
| Guanfacine | GUANFACINE | Actavis Pharma, Inc. | a81b956b-f004-4426-ba20-375ccf21eb71 | 2023-10-10 | Adverse reactions | PML56A160O |
| Guanfacine Hydrochloride | GUANFACINE | TWi Pharmaceuticals, Inc. | a0c2d95d-805c-4c7d-9733-52073a65218a | 2023-09-04 | Adverse reactions | PML56A160O |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 4ELV7Z65AP |
| GUANFACINE | GUANFACINE | Alembic Pharmaceuticals Limited | 983b3157-cbea-435d-ba32-9ee7ef95226a | 2023-08-10 | Warnings, Adverse reactions | PML56A160O |
| GUANFACINE | GUANFACINE HYDROCHLORIDE | Aurobindo Pharma Limited | e6d4fc3d-4169-44f1-bcb9-1188de40d4e5 | 2023-08-08 | Adverse reactions | PML56A160O |
| Guanfacine extended-release | GUANFACINE | A-S Medication Solutions | 07797c4a-a799-436b-a77c-a2861a811a99 | 2023-05-23 | Warnings, Adverse reactions | PML56A160O |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.